Clinical Research Directory

Blood Biomarkers for Screening of Alzheimer's Disease

Sponsor: Peking University First Hospital

Summary

The goal of this observational study is to estimate the screen performance of blood biomarkers of interest (Aβ40 and Aβ42, P-Tau181, P-Tau217, GFAP and NfL) in patients with Alzheimer's disease (AD), mild cognitive impairment due to AD, and cognitively normal individuals. The main questions it aims to answer are: * to identify core blood biomarker suitable for early screening of AD. * to establish a comprehensive model for the early identification of AD.

Official title: Blood-based Biomarkers for Early Alzheimer's Disease Screening

Key Details

Conditions

Interventions

Locations (1)